Aristides Capital LLC Purchases 14,641 Shares of Genpact Limited (NYSE:G)

Aristides Capital LLC raised its position in Genpact Limited (NYSE:GFree Report) by 21.7% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 82,133 shares of the business services provider’s stock after acquiring an additional 14,641 shares during the period. Genpact comprises 0.7% of Aristides Capital LLC’s portfolio, making the stock its 18th biggest position. Aristides Capital LLC’s holdings in Genpact were worth $3,528,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of the company. SRH Advisors LLC bought a new position in shares of Genpact in the 4th quarter valued at about $26,000. Atlas Capital Advisors Inc. grew its stake in Genpact by 55.8% in the fourth quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider’s stock valued at $26,000 after purchasing an additional 216 shares in the last quarter. Manchester Capital Management LLC acquired a new position in shares of Genpact during the 4th quarter worth approximately $38,000. Smartleaf Asset Management LLC raised its stake in shares of Genpact by 416.5% during the 4th quarter. Smartleaf Asset Management LLC now owns 971 shares of the business services provider’s stock worth $41,000 after purchasing an additional 783 shares in the last quarter. Finally, UMB Bank n.a. boosted its holdings in shares of Genpact by 55.7% in the 4th quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider’s stock valued at $52,000 after buying an additional 433 shares during the last quarter. Institutional investors and hedge funds own 96.03% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have issued reports on G shares. Needham & Company LLC upped their price target on shares of Genpact from $55.00 to $65.00 and gave the stock a “buy” rating in a research report on Friday, February 7th. Mizuho upped their target price on shares of Genpact from $45.00 to $55.00 and gave the company a “neutral” rating in a report on Monday, February 10th. TD Cowen upgraded Genpact from a “hold” rating to a “buy” rating and lifted their price target for the stock from $45.00 to $60.00 in a report on Friday, February 7th. Finally, Jefferies Financial Group upgraded Genpact from a “hold” rating to a “buy” rating and upped their price objective for the company from $44.00 to $55.00 in a research note on Tuesday, January 21st. Six analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, Genpact has a consensus rating of “Hold” and an average target price of $48.44.

View Our Latest Stock Report on G

Genpact Trading Down 3.7 %

Shares of NYSE:G opened at $47.08 on Friday. Genpact Limited has a 12-month low of $30.23 and a 12-month high of $56.76. The business has a 50 day moving average of $51.20 and a 200-day moving average of $45.44. The company has a quick ratio of 1.85, a current ratio of 2.16 and a debt-to-equity ratio of 0.50. The stock has a market cap of $8.27 billion, a PE ratio of 16.58, a P/E/G ratio of 1.84 and a beta of 1.06.

Genpact (NYSE:GGet Free Report) last released its quarterly earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.50%. As a group, equities research analysts forecast that Genpact Limited will post 3.21 earnings per share for the current year.

Genpact Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Tuesday, March 11th were issued a $0.17 dividend. The ex-dividend date of this dividend was Tuesday, March 11th. This represents a $0.68 dividend on an annualized basis and a yield of 1.44%. This is an increase from Genpact’s previous quarterly dividend of $0.15. Genpact’s payout ratio is currently 23.94%.

Insiders Place Their Bets

In other Genpact news, CEO Balkrishan Kalra sold 13,600 shares of the stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $48.89, for a total transaction of $664,904.00. Following the sale, the chief executive officer now directly owns 310,246 shares in the company, valued at $15,167,926.94. This represents a 4.20 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Piyush Mehta sold 12,000 shares of the business’s stock in a transaction that occurred on Friday, January 10th. The shares were sold at an average price of $42.83, for a total transaction of $513,960.00. Following the completion of the transaction, the senior vice president now owns 151,182 shares of the company’s stock, valued at $6,475,125.06. The trade was a 7.35 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 2.80% of the company’s stock.

Genpact Company Profile

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Featured Articles

Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:GFree Report).

Institutional Ownership by Quarter for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.